APA

Oosterhoff D., Lougheed S., van de Ven R., Lindenberg J., van Cruijsen H., Hiddingh L., Kroon J., van den Eertwegh A. J. M., Hangalapura B., Scheper R. J. & de Gruijl T. D. (20210129). Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. : Oncoimmunology.

Chicago

Oosterhoff Dinja, Lougheed Sinéad, van de Ven Rieneke, Lindenberg Jelle, van Cruijsen Hester, Hiddingh Lotte, Kroon Jan, van den Eertwegh Alfons J M, Hangalapura Basav, Scheper Rik J and de Gruijl Tanja D. 20210129. Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. : Oncoimmunology.

Harvard

Oosterhoff D., Lougheed S., van de Ven R., Lindenberg J., van Cruijsen H., Hiddingh L., Kroon J., van den Eertwegh A. J. M., Hangalapura B., Scheper R. J. and de Gruijl T. D. (20210129). Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. : Oncoimmunology.

MLA

Oosterhoff Dinja, Lougheed Sinéad, van de Ven Rieneke, Lindenberg Jelle, van Cruijsen Hester, Hiddingh Lotte, Kroon Jan, van den Eertwegh Alfons J M, Hangalapura Basav, Scheper Rik J and de Gruijl Tanja D. Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. : Oncoimmunology. 20210129.